| 000 | 01510 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515155934.0 | ||
| 264 | 0 | _c20090817 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1029-2403 | ||
| 024 | 7 |
_a10.1080/10428190802641979 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEve, Heather E | |
| 245 | 0 | 0 |
_aImpairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cMar 2009 |
||
| 300 |
_a463-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 | _aAntigens, CD34 |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Mobilization _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
| 700 | 1 | _aSeymour, John F | |
| 700 | 1 | _aRule, Simon A J | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 50 _gno. 3 _gp. 463-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428190802641979 _zAvailable from publisher's website |
| 999 |
_c18642138 _d18642138 |
||